semaglutide being taken off the market Novo Nordisk wins EU approval for Wegovy weight-loss pill Semaglutide Market Size, Share and

Appetite for change: GLP-1s and society What impact will GLP-1s have

Interestingly, there may even be indirect benefits for breast cancer patients: Weight loss after breast cancer is linked with better long-term outcomes

Elevated expression of AARS1 and lactylation of p53 are often associated with poor prognosis of patients, and administration of -alanine to antagonize the lactylation of p53, coupled with doxorubicin to activate the transcriptional activity of p53, can significantly inhibit the proliferation of tumor cells in animal models [23]

GLP-1s are only licensed for specific medical conditions theyre not a quick fix or cosmetic weight loss tool